Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2023
Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor PenetrationQing Wei, Teng Yang, Jiayu Zhu, et al.
Kidney International Reports|May 20, 2024
Effect of Telitacicept on Circulating Gd-IgA1 and IgA-Containing Immune Complexes in IgA NephropathyJincan Zan, Lijun Liu, Guisen Li, et al.
Molecular Microbiology|April 20, 2010
Characterization of a novel organelle in Toxoplasma gondii with similar composition and function to the plant vacuoleKildare Miranda, Douglas A Pace, Roxana Cintron, et al.
Ophthalmology and Therapy|July 20, 2024
Safety and Efficacy of Multiple Escalating Doses of RC28-E for Neovascular Age-Related Macular Degeneration: A Phase 1b TrialYingyi Lu, Xiaobing Yu, Youxin Chen, et al.
The Journal of Biological Chemistry|October 26, 2006
A solanesyl-diphosphate synthase localizes in glycosomes of Trypanosoma cruziMarcela Ferella, Andrea Montalvetti, Peter Rohloff, et al.
Rheumatology (Oxford, England)|July 3, 2023
Efficacy and safety of telitacicept in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trialDong Xu, Jianmin Fang, Shangzhu Zhang, et al.
Journal of Hematology & Oncology|January 4, 2024
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumorsQing Wei, Peijing Li, Teng Yang, et al.
Eclinicalmedicine|January 18, 2024
Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and expansion phase 1 trialYakun Wang, Jifang Gong, Airong Wang, et al.
Med (New York, N.Y.)|March 20, 2025
Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 studyXieqiao Yan, Juan Li, Huayan Xu, et al.
Microbiology and Immunology|March 6, 2024
N-glycosylation of the SARS-CoV-2 spike protein at Asn331 and Asn343 is involved in spike-ACE2 binding, virus entry, and regulation of IL-6Tuhin Das, Shuhong Luo, Hao Tang, et al.
Pageof 12